Resource Library
Do you know of a resource that would be a great addition to our collection? Let us know!
Search results
Ensuring affordability of over-the-counter birth control pills
CVS Caremark announces Opill on their covered drug list
Frequently asked questions about Opill
Over-the-counter access to hormonal contraception: A global perspective
Evaluation of adherence to a daily progestin-only pill in a simulated over-the-counter setting
Evaluation of consumer self-selection of a proposed over-the-counter, progestin-only daily oral contraceptive
Everything you need to know about the first over-the-counter birth control pill
Interest in over-the-counter progestin-only pills among transgender, nonbinary, and gender-expansive individuals in the United States
Letter from Free the Pill coalition steering committee to Perrigo
“As cost remains the top challenge for consumer access, it is incumbent upon all of us to remain committed to eliminating barriers to contraceptive equity and to work as hard as we can to create a fair and equitable marketplace for all. Now, more than ever, we must prioritize contraceptive equity—and for Opill, that means fulfilling Perrigo’s promise to set an affordable price and establish a robust consumer assistance program that allows everyone to benefit from this groundbreaking advancement in reproductive health.”
— Free the Pill coalition steering committee
Comment from Ibis Reproductive Health on Request for Information: Coverage of Over-the-Counter Preventive Services
“OTC coverage is key to equitable access and in the case of contraceptive care, it is also a reproductive justice issue. We know that barriers to contraception fall harder on communities that experience systemic inequities due to structural racism, bias, and other forms of oppression, and it is imperative that policies are designed to break down these barriers, not uphold them.”
— Kelly Blanchard, Robyn Elliott, Victoria Nichols, and Britt Wahlin